named programs · 5 · from sources
What they call their work
Access to Medicines PharmD Program
Summer internship program offering PharmD students real-world experience in drug development with partner organizations to expand access to medicines for vulnerable populations.
Convergence Forum Fellowship Program
Fellowship supporting first-time female and underrepresented minority CEOs in healthcare innovation, providing access to leadership networks and resources to advance health equity.
Genomics Frontiers Symposium
Annual event bringing together researchers, clinicians, and policymakers to advance genomics in Africa and improve public health outcomes in Rwanda and beyond.
Global Access Fellowship
Supports PharmD candidates and early-career professionals in advancing equitable access to medicines through placements with partner organizations globally.
No Patient Left Behind Summer Biotech Fellowship
10-week fellowship combining health economics, investing, and insurance design education with mentorship from industry leaders to train future biotech innovators.
activities · 8 groups
What they do
-
Healthcare Workforce Training & Career Pathways 2 activities
- Delivering educational programs and training for future biopharma professionalsLaunches academic and internship programs such as the “Making Medicines” course at UNC and the Diversity in Pharma Internship Program to train diverse students in drug development and global access to medicines. Real-world training is delivered through multi-organization partnerships.
- Expanding diversity in clinical trials and drug development careersWorks to increase the diversity of patients and physicians in clinical trials and supports career development in drug development and patient access, with evidence showing 85.7% of participating PharmD candidates changing their career paths as a result.
-
-
Community Health Equity Initiatives 1 activity
- Advancing health equity through policy and partnership frameworksEmbeds health equity commitments into program design and contractual agreements with partners, and promotes diversity in clinical trials through co-founding initiatives such as CARER. Integrates health equity as a guiding principle across organizational activities.
-
-
Industry Research and Benchmarking 1 activity
- Conducting research and thought leadership in DEI and ESG for biopharmaProduces white papers and thought leadership on diversity, equity, inclusion, and ESG topics, offering co-authorship opportunities to corporate partners to advance industry-wide practices.
-
-
Impact Investing Knowledge & Technology Platforms 1 activity
- Developing and promoting the Global Access Scorecard for health innovation assessmentCreates and implements a Global Access Scorecard that applies ESG principles to evaluate biotech and healthcare innovations based on patient benefit, equity, scientific viability, and governance, with the goal of guiding impact investment decisions.
-
-
Medical Research Funding 1 activity
- Funding and incubating early-stage health technology companies focused on health equityInvests in and incubates early-stage companies developing therapies and technologies for underserved patient groups, including through the creation and support of subsidiary biotechnology companies. Evidence indicates the organization has been involved in the incubation of at least 16 subsidiary companies and multiple successful initial public offerings.
-
-
HIV Research and Advocacy Funding 1 activity
- Funding global access initiatives for gene therapies and underserved populationsProvides financial and operational support to expand global access to gene therapies, particularly for HIV and sickle cell disease in low- and middle-income countries, through strategic partnerships and coalition-building.
-
-
Leadership Development Programs 1 activity
- Providing fellowship and leadership development programs for underrepresented biopharma leadersOffers Global Access Fellowships and Legal Fellowships focused on impact investing and access to medicines, supports underrepresented CEOs in attending leadership conferences, and provides fellowship support for CEOs developing equitable healthcare solutions.
-
-
Alzheimer's Research and Support Services 1 activity
- Supporting impact research through partnership in global clinical trialsPartners with the Davos Alzheimer Collaborative to design and conduct the first Alzheimer's clinical trial in Africa, contributing drug materials, trial design expertise, and digital health support.
-
financials · form 990 · fy2024
revenue
Total revenue$307K
Contributions & grants$305K99%
Program service revenue$00%
Investment income$2K1%
Other revenue$0
expenses
Total expenses$287K
Program expenses57%
Admin / overhead35%
Fundraising8%
Salaries & benefits$0
Grants paid out$23K
Largest expense lineProfessional Fees
balance sheet
Total assets$409K
Cash$399K
Investments$0
Liabilities$24K
Net assets$385K
Liquid reserves16.7 mo
5 years on record · 2020–2024 · YoY revenue +147.7%
leadership · form 990 part vii · fy2024
Who runs it
paid leadership · 5
| Name | Title | Hours/wk | Compensation |
|---|---|---|---|
| MATTHEW GLINE | DIRECTOR AND SECRETARY | 0 | $210.66M |
| ERIC VENKER | DIRECTOR | 0 | $21.38M |
| RAKHI KUMAR TO 22025 | DIRECTOR AND TREASURER | 0 | $6.10M |
| DANIEL PATTERSON | DIRECTOR | 0 | $1.99M |
| LINDSAY ANDROSKI | DIRECTOR, PRESIDENT AND CEO | 4 | $1.16M |
relationships · 37
Who they work with
- Aga Khan Hospital Partner — Partner institution in Nairobi, Kenya involved in the expansion of the Davos Alzheimer Collaborative’s clinical trial
- CARER Partner — Founding member; focused on promoting diversity in clinical trials
- Calla Lily Clinical Care Partner — Hosts PharmD Global Access Fellows through a partnership with Roivant Social Ventures.
- Calla Lily Clinical Care Partner — Partnered with RSV to create summer internship opportunities for PharmD students and co-host the 2025 Global Access Fellowship in Women’s Health.
- Davos Alzheimer Collaborative Partner — Collaborating to design and conduct the first Alzheimer's clinical trial in Africa
- Elutia Partner — Hosts a PharmD Intern through a partnership with Roivant Social Ventures.
- Encora Partner — Incubated startup developing a device to reduce hand tremors for people with Parkinson’s Disease
- Global Gene Therapy Initiative Partner — Co-founded international working group to expand access to gene therapies in low- and middle-income countries
- GoodLife Rwanda Partner — Hosts PharmD Global Access Fellows through a partnership with Roivant Social Ventures.
- Harvard Business Review Network — Member of the Harvard Business Review Advisory Council.
- LA Center for Law and Justice Partner — Member of the Leadership Council of the LA Center for Law and Justice.
- MIT Alumni Association Partner — Served on the Board of the MIT Alumni Association.
- MIT Annual Fund Partner — Chair of the MIT Annual Fund Board.
- Med Aditus Partner — Hosts PharmD Global Access Fellows through a partnership with Roivant Social Ventures.
- Med Aditus Partner — Provided fellowship placements to support development of affordable medicines for underserved patients in Sub-Saharan Africa
- Med Aditus International Partner — Partnered with RSV on the 2025 Global Access Fellowship, providing PharmD candidates with experience in healthcare innovation and equity.
- No Patient Left Behind Partner — Hosts a PharmD Access Fellow through a partnership with Roivant Social Ventures.
- No Patient Left Behind Partner — Partnered with RSV to create summer internship opportunities for PharmD students and co-host the NPLB Summer Biotech Fellowship Program.
- Nucleate Partner — Partnered with RSV to host Activator Demo Day, a biotech pitch competition for early-stage startups, in Chicago.
- Pulmovant Partner — Hosts a PharmD Intern through a partnership with Roivant Social Ventures.
- Pulmovant Partner — Partnered with RSV to create summer internship opportunities for PharmD students.
- Roivant Sciences Partner — Co-launched the Diversity in Pharma Internship Program to provide drug development experience to diverse PharmD students
- Roivant Sciences Partner — Collaborated with RSV to provide internship opportunities for PharmD students in drug development and patient access.
- Roivant Sciences Partner — Hosts PharmD Interns and Post-Doctoral Fellows through a partnership with Roivant Social Ventures.
- Roivant Sciences Partner — Leverages resources and talent from Roivant Sciences to support healthcare startups.
- Roivant Sciences Partner — Provides donated infrastructure, talent, and networks to support Roivant Social Ventures.
- Roivant Sciences Partner — Provides funding for RSV's overhead, including employee compensation, enabling full allocation of external donations to programmatic needs.
- SBP Partner — Launched a real-world training program to accelerate therapeutic innovation and train diverse students
- UNC Eshelman School of Pharmacy Partner — Launched the "Making Medicines" course to educate PharmD students on drug development and global access
- UNC Eshelman School of Pharmacy Partner — Partner institution whose PharmD students participate in RSV internship and fellowship programs.
+ 7 more
strategies · 4
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Early-Access Integration via Global Access Scorecardmethodology: early_access_integrationBy integrating global access considerations into early investment decisions using the Global Access Scorecard, the organization prevents delays in medicine access and reduces health disparities because equity is proactively designed into the development pathway rather than retrofitted later.
- Expertise-Plus-Funding Model to Amplify Systemic Changemethodology: expertise_plus_fundingBy combining industry expertise with charitable funding, the organization drives systemic change in health care because specialized knowledge paired with dedicated resources enables more effective and sustainable interventions than either element alone.
- Reinvestment Model for Sustained Social Impactmethodology: reinvestment_modelBy reinvesting financial returns from investments into new health initiatives, the organization creates a self-sustaining cycle of impact because ongoing funding enables long-term innovation and scalability without reliance on external donations.
- Venture Philanthropy in Early-Stage Health Technologiesmethodology: venture_philanthropyBy investing in early-stage health technologies through a venture philanthropy approach, the organization improves medicine accessibility for underserved populations because high-risk, innovation-driven projects can be nurtured to scale where traditional funders may not engage.